FDA-Drug2026-09-16Class IPROCESSING DEFECT
Baxter Dextrose Injection 70% recalled for stainless steel particles
What this means
Baxter Healthcare identified stainless steel particles in certain 2000 mL bags of Dextrose Injection, USP 70%. The contamination affected 606 bags (Lot #Y495066, expiration July 31, 2027) distributed nationwide. No injuries have been reported.
- Do not use affected bags of Dextrose Injection, USP 70%, Lot #Y495066.
- Contact Baxter Healthcare or your pharmacy for guidance on safe disposal and replacement.
- Check your facility's inventory for the recalled lot number.
The agency's original wording
Hazard
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Intended for
All ages (under 0 months)
Illnesses reported
None reported
Sold states
U.S. Nationwide.
Affected count
606 bags
Manufactured in
1 Baxter Pkwy, Deerfield, IL, United States
Products
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0850-2026More Baxter recalls
- FDA-Drug2026-09-09Baxter 0.9% Sodium Chloride Injection recalled for fiberglass contamination
- FDA-Device2026-09-09Baxter Novum IQ Syringe Pump recalled for software issue during multi-syringe infusion
- FDA-Device2026-09-09Baxter Novum IQ Syringe Pump recalled for software issue during multi-syringe infusion
- FDA-Drug2026-09-09Baxter Clindamycin Phosphate injection recalled for manufacturing compliance deviations
- FDA-Drug2026-09-09Baxter Vancomycin Injection recalled for CGMP manufacturing deviations
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.